A new crystal form of atracurium besylate and its crystallization method
By using a crystallization method with a specific ratio of acetone and ethyl acetate solvents and temperature control, the problem of low purification efficiency of atracurium besylate in the prior art has been solved, achieving high purity and high yield crystallization results, which are suitable for industrial production.
Patent Information
- Application Number
- CN202111465073.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-12-03
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2041-12-03
AI Technical Summary
Existing technologies are difficult to effectively purify atracurium besylate in industrial production due to problems such as complex operation, low yield, high solvent hazard, slow crystallization rate, and low purity.
A novel crystalline form of atracurium cis-benzenesulfonate was prepared using acetone and ethyl acetate as solvents through a crystallization method with specific ratios and temperature control, thereby reducing solvent usage and optimizing the crystallization process.
Atracurium cis-benzenesulfonic acid crystallization with high purity (99.89%) and high yield (99.08%) was achieved, reducing solvent costs and environmental risks, and improving production efficiency.
Smart Images

Figure CN114014806B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of purification of atracurium besylate, and particularly relates to a new crystal form of atracurium besylate and a crystallization method thereof. Background Art
[0002] The chemical name of atracurium besylate is: (1R,1'R,2R,2'R)-2,2'-(3,11-dioxo-4,10-dioxotridecanomethylene)bis(1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-veratrylisoquinoline) dibenzenesulfonate.
[0003] Cis-atracurium besylate is a neuromuscular blocker developed by GlaxoSmithKline (GSK), with the trade name NimbexTM. Cis-atracurium besylate is metabolized through non-hepatic and non-renal pathways, and its muscle relaxant effect is 3 times stronger than that of atracurium besylate. It has the clinical advantages of rapid onset, strong effect, rapid recovery, no release of histamine, little cardiovascular effect, no accumulation, and no muscle relaxant effect and no toxicity of metabolites. It is mainly suitable for general anesthesia, and can be widely used in endotracheal intubation, liver and kidney dysfunction, cardiovascular surgery, and elderly and pediatric patients.
[0004] US5453510 first gave a method for synthesizing atracurium besylate, and obtained a product with an isomer purity of 99% by preparative chromatography. Due to the limitation of preparative chromatography, this method cannot be applied to industrial production.
[0005] US20100234602 reports two crystal forms of atracurium benzenesulfonate, and a method for purifying atracurium benzenesulfonate tetrafluoroborate. First, the crude atracurium benzenesulfonate is added to a tetrafluoroboric acid aqueous solution to react and obtain its tetrafluoroborate, then the tetrafluoroborate is purified by methods such as crystallization and beating, and finally the tetrafluoroborate is hydrolyzed under acidic conditions to obtain a product with higher purity. The disadvantage of this method is that the operation is complicated, the yield is low, and the improvement of purity after repeated operation is very limited. The cumbersome operating process increases the cost of raw materials, reduces the time-space yield, and is not suitable as an industrial method.
[0006] Structurally, the atracurium cisbenzenesulfonate molecule is connected by two larger rigid fragments through a longer flexible chain. This molecular structure has a lot of stable conformations, and the crystallization process requires the molecules to be arranged in a unified conformation. Since there are many stable conformations, it takes a long time to transform the conformation, so the crystallization process of atracurium cisbenzenesulfonate is very slow. In addition, the two quaternary ammonium salt structures in the molecule cause atracurium cisbenzenesulfonate to be highly hygroscopic in solid form. When the water content in the solvent is high, an oily substance will be formed, which cannot be effectively crystallized. The variable conformation makes it difficult to find an effective crystallization condition for atracurium cisbenzenesulfonate.
[0007] WO2010128518 provides a purification condition for atracurium benzenesulfonate. Atracurium benzenesulfonate is dissolved in a mixed solvent of acetonitrile and isopropanol to form an oily substance, and then ethyl acetate is added to form a two-phase system, and impurities in the oily substance are washed away with ethyl acetate. The atracurium benzenesulfonate solution is then added dropwise to ether to precipitate a solid. In the two-phase extraction system of this method, the lower layer of the oily substance is viscous and has poor operability; and a large amount of solvent ether is required, and the solvent has an extremely low flash point and is highly dangerous, and is a controlled substance that is easy to make drugs, which is not conducive to production and use.
[0008] EP0882020 provides a crystallization scheme using a composite solvent system of acetonitrile-isopropanol-toluene-ethyl acetate-n-heptane. This method is too special and difficult to reproduce, and it is rare to use such a complex solvent system in a one-step crystallization operation. Summary of the invention
[0009] In view of the deficiencies in the prior art, the object of the present invention is to provide a new crystal form of atracurium besylate and a crystallization method thereof.
[0010] In order to achieve the purpose of the invention, the present invention adopts the following technical solutions:
[0011] In a first aspect, the present invention provides a new crystal form of atracurium besylate, wherein the X-ray diffraction pattern of the new crystal form of atracurium besylate has main characteristic peaks at 2θ at 16.01±0.2°, 18.49±0.2°, 21.42±0.2°, 22.95±0.2°, 24.89±0.2°, 27.60±0.2°, 30.08±0.2°, 31.17±0.2°, 32.19±0.2° and 35.92±0.2°.
[0012] Further preferably, the X-ray diffraction pattern of the new crystal form of atracurium besylate has 2θ at 15.08±0.2°, 16.01±0.2°, 18.49±0.2°, 20.11±0.2°, 21.42±0.2°, 22.95±0.2°, 23.27±0.2°, 23.80±0.2°, 24.89±0.2°, 26.16±0.2°, 27.12±0.2°, 27.60±0.2°, 27.78±0.2°, 29. There are characteristic peaks at 52±0.2°, 30.08±0.2°, 30.81±0.2°, 31.17±0.2°, 31.56±0.2°, 32.19±0.2°, 32.66±0.2°, 32.99±0.2°, 34.50±0.2°, 35.14±0.2°, 35.92±0.2°, 37.34±0.2°, 37.66±0.2°, 38.26±0.2°, 39.11±0.2° and 39.50±0.2°.
[0013] The purity of the new crystal form of atracurium besylate as described above involved in the present invention can reach 99.89%, and the quality is greatly improved compared with the crystal form of atracurium besylate disclosed in the prior art.
[0014] In a second aspect, the present invention provides a method for crystallizing the new crystalline citrate atracurium besylate as described in the first aspect, the crystallization method comprising the following steps: dissolving amorphous citrate atracurium besylate with acetone, and then adding the atracurium citrate into an ethyl acetate solvent for crystallization to obtain the new crystalline citrate atracurium besylate.
[0015] The crystallization method of the new crystal form of atracurium benzenesulfonate involved in the present invention only involves two organic solvents, acetone and ethyl acetate, and the amount used is small, wherein the amount of acetone used is only 0.8-2 times the weight of the amorphous atracurium benzenesulfonate, and the amount of ethyl acetate used is only 7-10 mL of ethyl acetate per gram of amorphous atracurium benzenesulfonate. Compared with the prior art (generally using an organic solvent 20-40 times the volume of amorphous atracurium benzenesulfonate), the amount of organic solvent used in the present application is greatly reduced, which not only saves costs but is also more environmentally friendly.
[0016] In addition, the crystallization time of the new crystal form of atracurium besylate involved in the present invention is shorter than that of the prior art (generally 5-30 hours), and the method of the present application only takes 1.5-2.5 hours, which is more suitable for industrial production from the perspective of magnification, and greatly improves production efficiency. At the same time, the crystal quality of atracurium besylate obtained by the crystallization method involved in the present application is much higher than that of the prior art, the purity can reach 99.85%, and the yield can reach 99.08%, that is, the present invention provides a good crystallization condition and purification method of atracurium besylate.
[0017] Preferably, the amorphous atracurium besylate is amorphous atracurium besylate that has been subjected to a precipitation treatment.
[0018] Preferably, the amount of acetone used is 0.8-2 times the weight of the amorphous atracurium besylate, for example, 0.8 times, 1 times, 1.2 times, 1.4 times, 1.5 times, 1.6 times, 1.8 times or 2 times, etc. Other specific point values within the above numerical range can be selected, and they will not be repeated here one by one.
[0019] Here, acetone is specifically selected to dissolve amorphous cis-atracurium benzenesulfonate because acetone has good solubility for cis-atracurium benzenesulfonate, is a commonly used solvent, and is easily available. The specific amount selected is 0.8-2 times the weight of amorphous cis-atracurium benzenesulfonate because if the amount of acetone added is further increased, the solubility of cis-atracurium benzenesulfonate in the crystallization system will increase, reducing the yield. If the amount of acetone added is further reduced, the impurities in the crystallization system cannot be effectively dissolved in the mixed solvent, thereby reducing the purity of the crystallized cis-atracurium benzenesulfonate.
[0020] Preferably, the dissolving with acetone is carried out at a temperature of 18-42°C, for example, 18°C, 19°C, 20°C, 21°C, 22°C, 23°C, 24°C, 25°C, 26°C, 27°C, 28°C, 29°C, 30°C, 31°C, 32°C, 33°C, 34°C, 35°C, 36°C, 37°C, 38°C, 39°C, 40°C, 41°C or 42°C, etc. Other specific point values within the above numerical range can be selected, which will not be repeated here.
[0021] Preferably, the amount of ethyl acetate used is 7-10 mL of ethyl acetate per g of amorphous cis-atracurium besylate, for example, 7 mL, 7.5 mL, 8 mL, 8.2 mL, 8.5 mL, 9 mL, 9.2 mL, 9.5 mL, 9.8 mL or 10 mL, etc. Other specific point values within the above numerical range can be selected, and they will not be repeated here one by one.
[0022] Here, the acetone solution of amorphous atracurium benzenesulfonate is specifically selected to be added to ethyl acetate because ethyl acetate is almost insoluble in atracurium benzenesulfonate and is miscible with acetone. Ethyl acetate is a commonly used solvent, safe and easily available, and the specific selection of using 7-10 mL per g of amorphous atracurium benzenesulfonate is because if the amount of ethyl acetate used is further increased, the system will become viscous, and the crystallized atracurium benzenesulfonate will become viscous and have more impurities. If the amount of ethyl acetate used is further reduced, the amount of crystallization will be reduced, the yield will be reduced, and even no crystals will be precipitated after the precipitated crystals are dissolved.
[0023] Preferably, the method of adding into the ethyl acetate solvent is dropwise addition.
[0024] Preferably, the dropping rate is 10-15 mL / h, for example 10 mL / h, 10.5 mL / h, 11 mL / h, 12 mL / h, 12.5 mL / h, 13 mL / h, 14.5 mL / h or 15 mL / h, etc. Other specific point values within the above numerical range can be selected and will not be described one by one here.
[0025] The dropping needs to be performed at a slower speed, because the slow dropping can allow the atracurium besylate dissolved in the acetone to have more time to slowly precipitate without being wrapped with impurities, and the crystal purity is higher.
[0026] Preferably, the dropwise addition is carried out at a temperature of 18-42°C, for example, 18°C, 19°C, 20°C, 21°C, 22°C, 23°C, 24°C, 25°C, 26°C, 27°C, 28°C, 29°C, 30°C, 31°C, 32°C, 33°C, 34°C, 35°C, 36°C, 37°C, 38°C, 39°C, 40°C, 41°C or 42°C, etc. Other specific point values within the above numerical range can be selected, so they will not be described one by one here.
[0027] Preferably, the dropwise addition is carried out under stirring conditions, and the stirring speed is 200-235rpm, for example, 200rpm, 205rpm, 210rpm, 215rpm, 225rpm, 230rpm or 235rpm, etc. Other specific point values within the above numerical range can be selected, and they will not be described one by one here.
[0028] Preferably, after the dropwise addition is completed, the crystal is continued to be grown under stirring conditions for 1.5-2.5 hours, for example, 1.5 hours, 1.6 hours, 1.7 hours, 1.8 hours, 1.9 hours, 2.0 hours, 2.1 hours, 2.2 hours, 2.3 hours, 2.4 hours or 2.5 hours, etc. Other specific point values within the above numerical range can be selected, and they will not be described one by one here.
[0029] Preferably, the stirring speed is 75-90rpm, for example, 75rpm, 78rpm, 80rpm, 83rpm, 85rpm, 88rpm or 90rpm, etc. Other specific point values within the above numerical range can be selected and will not be described here one by one.
[0030] Preferably, the crystal growing is carried out at 18-42°C, for example, 18°C, 19°C, 20°C, 21°C, 22°C, 23°C, 24°C, 25°C, 26°C, 27°C, 28°C, 29°C, 30°C, 31°C, 32°C, 33°C, 34°C, 35°C, 36°C, 37°C, 38°C, 39°C, 40°C, 41°C or 42°C, etc. Other specific point values within the above numerical range can be selected, and they will not be described one by one here.
[0031] Preferably, after the crystallization is completed, suction filtration and drying are performed.
[0032] Preferably, the drying is carried out by vacuum drying, the vacuum drying temperature is 25-35°C, for example, 25°C, 26°C, 27°C, 28°C, 29°C, 30°C, 31°C, 32°C, 33°C, 34°C or 35°C, and the time is 18-48h, for example, 18h, 20h, 24h, 28h, 30h, 32h, 36h, 40h, 42h, 45h or 48h, and other specific point values within the above numerical range can be selected, which will not be repeated here.
[0033] As a preferred technical solution of the present invention, the crystallization method comprises the following steps:
[0034] (1) dissolving the desolvated amorphous atracurium besylate with 0.8-2 times the weight of acetone at 22-28° C.;
[0035] (2) adding the acetone solution obtained in step (1) dropwise into an ethyl acetate solvent at a dropping speed of 10-15 mL / h at 18-42° C. for crystallization, stirring at a speed of 200-235 rpm while dropping, and using 7-10 mL of ethyl acetate per gram of amorphous atracurium besylate;
[0036] (3) After the dropwise addition is completed, the mixture is stirred at 75-90 rpm and grown at 18-42° C. for 1.5-2.5 h, then filtered and vacuum dried at 25-35° C. for 18-48 h to obtain the new crystalline form of atracurium besylate.
[0037] Compared with the prior art, the present invention has the following beneficial effects:
[0038] The crystallization method of the new crystal form of atracurium benzenesulfonate involved in the present invention only involves two organic solvents, acetone and ethyl acetate, and the amount used is small, wherein the amount of acetone used is only 0.8-2 times the weight of the amorphous atracurium benzenesulfonate, and the amount of ethyl acetate used is only 7-10 mL of ethyl acetate per gram of amorphous atracurium benzenesulfonate. Compared with the prior art (generally using an organic solvent 20-40 times the volume of amorphous atracurium benzenesulfonate), the amount of organic solvent used in the present application is greatly reduced, which not only saves costs but is also more environmentally friendly.
[0039] In addition, the crystallization time of the new crystal form of atracurium besylate involved in the present invention is shorter than that of the prior art (generally 5-30 hours), and the method of the present application only takes 1.5-2.5 hours, which is more suitable for industrial production from the perspective of magnification, and greatly improves production efficiency. At the same time, the crystal quality of atracurium besylate obtained by the crystallization method involved in the present application is much higher than that of the prior art, the purity can reach 99.89%, and the yield can reach 99.12%, that is, the present invention provides a good crystallization condition and purification method of atracurium besylate. BRIEF DESCRIPTION OF THE DRAWINGS
[0040] Figure 1 is the XRD spectrum of the amorphous atracurium besylate raw material used in Example 1-7 and Comparative Example 1-2;
[0041] Figure 2 This is a graph showing the HPLC test results of the product obtained in Example 1;
[0042] Figure 3 This is a DSC-TGA test result diagram of the product obtained in Example 1;
[0043] Figure 4 This is a test result diagram of the water vapor dynamic adsorption performance (DVS) of the product obtained in Example 1;
[0044] Figure 5 is the XRD spectrum of the product obtained in Example 1;
[0045] Figure 6 is the XRD spectrum of the product obtained in Example 3;
[0046] Figure 7 is the XRD spectrum of the product obtained in Example 4;
[0047] Figure 8 is the XRD spectrum of the product obtained in Example 5;
[0048] Fig. 9 is the XRD spectrum of the product obtained in Example 6;
[0049] Fig.10 is the XRD spectrum of the product obtained in Comparative Example 1;
[0050] Fig.11 It is the XRD spectrum of the product obtained in Comparative Example 2. DETAILED DESCRIPTION
[0051] The technical solution of the present invention is further described below by specific implementation methods. It should be understood by those skilled in the art that the embodiments are only to help understand the present invention and should not be regarded as specific limitations of the present invention.
[0052] The amorphous cis-atracurium benzenesulfonate involved in the following examples or comparative examples is prepared with reference to the preparation method in the patent document (CN201710768568.1, a new crystal form of cis-atracurium benzenesulfonate and a purification method thereof), and the preparation process is to obtain a crude product of atracurium benzenesulfonate by neutralization, addition, methylation and other steps of R-tetrahydropapaverine-N-acetyl-L-leucine salt, and then the isomers are separated by column to obtain amorphous cis-atracurium benzenesulfonate with a purity of 98.56%. Figure 1 shown.
[0053] The method for determining the purity of the products involved in the following examples or comparative examples is as follows: cisatracurium besylate is tested by HPLC, and the percentage content by area normalization method is taken as the purity.
[0054] The calculation method of the product yield involved in the following embodiments or comparative examples is as follows: the content of amorphous cis-atracurium benzenesulfonate before crystallization (C1) and the content of cis-atracurium benzenesulfonate after crystallization and drying (C2) are measured by external standard method, the weight of amorphous cis-atracurium benzenesulfonate before crystallization is W1, the weight of cis-atracurium benzenesulfonate after crystallization and drying is W2, and the yield is (W2×C2) / (W×C1)×100%.
[0055] Example 1
[0056] This embodiment provides a crystallization method of atracurium besylate and a new crystal form of atracurium besylate obtained, and the operation is as follows:
[0057] (1) 10.02 g of amorphous atracurium besylate solid (purity 98.56%) after desolvation was dissolved in 10.00 g of acetone at 22° C. by stirring;
[0058] (2) adding the acetone solution obtained in step (1) dropwise into 80 mL of ethyl acetate solvent at 25° C. for crystallization, stirring at 210 rpm while adding dropwise, and completing the addition in 50 min;
[0059] (3) After the addition was completed, the mixture was allowed to grow for 2 h at 20 ° C. and 75 rpm under stirring, and then filtered to obtain a filter cake, which was vacuum dried at 25 ° C. for 48 h. The resulting material was 9.80 g of atracurium besylate crystals with a purity of 99.89% and a yield of 99.12%.
[0060] The obtained product was subjected to HPLC detection, DSC-TGA test and water vapor dynamic adsorption performance (DVS) test, and the results were as follows: Figure 2 , Figure 3 , Figure 4 shown.
[0061] The obtained product was tested by XRD spectrum. Figure 5The characteristic data of the XRD spectrum are shown in Table 1:
[0062] Table 1
[0063]
[0064]
[0065] Example 2
[0066] This embodiment provides a crystallization method of atracurium besylate and a new crystal form of atracurium besylate obtained, and the operation is as follows:
[0067] (1) 10.03 g of amorphous atracurium besylate solid (purity 98.56%) after desolvation was dissolved in 10.00 g of acetone at 25° C. by stirring;
[0068] (2) adding the acetone solution obtained in step (1) dropwise into 80 mL of ethyl acetate solvent at 25° C. for crystallization, stirring at 210 rpm while adding dropwise, and completing the addition in 55 min;
[0069] (3) After the addition was completed, the mixture was stirred at 25° C. and 80 rpm for 2 h, and then filtered to obtain a filter cake, which was vacuum dried at 25° C. for 48 h. The resulting mixture obtained was 9.86 g of atracurium besylate crystals with a purity of 99.85% and a yield of 98.53%.
[0070] The obtained product was subjected to XRD spectrum detection, and the crystal form was the same as that in Example 1.
[0071] Example 3
[0072] This embodiment provides a crystallization method of atracurium besylate and a new crystal form of atracurium besylate obtained, and the operation is as follows:
[0073] (1) 10.02 g of amorphous atracurium besylate solid (purity 98.56%) after desolvation was dissolved in 10.00 g of acetone at 18° C. by stirring;
[0074] (2) adding the acetone solution obtained in step (1) dropwise into 100 mL of ethyl acetate solvent at 18° C. for crystallization, stirring at 220 rpm while adding dropwise, and completing the addition in 58 min;
[0075] (3) After the addition was completed, the mixture was allowed to grow for 2.5 h at 18 ° C. and 75 rpm, and then filtered to obtain a filter cake, which was vacuum dried at 30 ° C. for 30 h. The resulting mixture obtained was 9.91 g of atracurium besylate crystals with a purity of 99.60% and a yield of 99.08%.
[0076] The obtained product was tested by XRD spectrum. Figure 6 shown.
[0077] Example 4
[0078] This embodiment provides a crystallization method of atracurium besylate and a new crystal form of atracurium besylate obtained, and the operation is as follows:
[0079] (1) 10.02 g of amorphous atracurium besylate solid (purity 98.56%) after desolvation was dissolved in 20.00 g of acetone at 35° C. by stirring;
[0080] (2) adding the acetone solution obtained in step (1) dropwise into 80 mL of ethyl acetate solvent at 35° C. for crystallization, stirring at 230 rpm while adding dropwise, and completing the addition in 56 min;
[0081] (3) After the addition was completed, the mixture was stirred at 35° C. and 75 rpm for 1.5 h, and then filtered to obtain a filter cake, which was vacuum dried at 35° C. for 18 h. The resulting mixture obtained was 9.73 g of atracurium besylate crystals with a purity of 99.35% and a yield of 97.63%.
[0082] The obtained product was tested by XRD spectrum. Figure 7 shown.
[0083] Example 5
[0084] This embodiment provides a method for crystallizing atracurium besylate, which is performed as follows:
[0085] (1) 10.05 g of amorphous atracurium besylate solid (purity 98.56%) after desolvation was dissolved in 20.00 g of acetone at 42° C. by stirring;
[0086] (2) adding the acetone solution obtained in step (1) dropwise into 100 mL of ethyl acetate solvent at 42° C. for crystallization, stirring at 235 rpm while adding dropwise, and completing the addition in 58 min;
[0087] (3) After the addition was completed, the mixture was allowed to grow for 2 h at 42 °C and 80 rpm under stirring, and then filtered to obtain a filter cake, which was vacuum dried at 40 °C for 18 h to obtain 9.82 g of atracurium besylate crystals with a purity of 99.23% and a yield of 98.11%.
[0088] The obtained product was tested by XRD spectrum. Figure 8 shown.
[0089] Example 6
[0090] This embodiment provides a method for crystallizing atracurium besylate. The operation is different from that of Example 1 only in that the dripping speed in step (2) is too fast. The dripping is completed within 30 minutes. Other conditions remain unchanged. The material is collected with a purity of 99.05% and a yield of 98.08%, which is an amorphous powder.
[0091] The obtained product was tested by XRD spectrum. Fig. 9 shown.
[0092] Example 7
[0093] This embodiment provides a method for crystallizing atracurium besylate. The operation is different from that of Example 1 only in that the amount of acetone used in step (1) is too much, that is, 10.03 g of amorphous atracurium besylate solid (purity 98.56%) after desolvation is stirred and dissolved with 30.00 g of acetone at 25° C., and other conditions remain unchanged. The material is collected with a purity of 99.63% and a yield of 97.28%.
[0094] The obtained product was subjected to XRD spectrum detection, and the crystal form was the same as that in Example 1.
[0095] Example 8
[0096] This embodiment provides a method for crystallizing atracurium besylate. The operation is different from that of Example 1 only in that the amount of ethyl acetate used in step (2) is too much, that is, the acetone solution obtained in step (1) is added dropwise to 150 mL of ethyl acetate solvent at 25° C. for crystallization, and other conditions remain unchanged. The material is collected with a purity of 99.09% and a yield of 98.82%.
[0097] The obtained product was subjected to XRD spectrum detection, and the crystal form was the same as that in Example 1.
[0098] Comparative Example 1
[0099] This comparative example provides a crystallization method of atracurium besylate, the operation is different from that of Example 1 only in that acetone is replaced by ethylene dichloride, and other conditions remain unchanged, and the material is collected with a purity of 98.99% and a yield of 96.96%. It is an amorphous powder.
[0100] The obtained product was tested by XRD spectrum. Fig.10 shown.
[0101] Comparative Example 2
[0102] This comparative example provides a crystallization method of atracurium besylate, the operation is different from that of Example 1 only in that ethyl acetate is replaced by toluene, and other conditions remain unchanged, and the material is collected with a purity of 98.88% and a yield of 98.64%. It is an amorphous powder.
[0103] The obtained product was tested by XRD spectrum. Fig.11 shown.
[0104] From the above examples and comparative examples, it can be seen that the amount of organic reagent used in the crystallization method of atracurium besylate involved in the present invention is relatively small, and the crystallization time is short; at the same time, the obtained atracurium besylate has a crystalline form, high quality, purity of more than 98.29%, and yield of more than 97.28%. In addition, the amount of acetone and ethyl acetate, the dripping speed, etc. will affect the purity, yield or crystal form of the product.
[0105] The applicant declares that the present invention illustrates a new crystal form of atracurium besylate and its crystallization method through the above-mentioned embodiments, but the present invention is not limited to the above-mentioned embodiments, that is, it does not mean that the present invention must rely on the above-mentioned embodiments to be implemented. Those skilled in the art should understand that any improvement of the present invention, equivalent replacement of various raw materials of the product of the present invention, addition of auxiliary components, selection of specific methods, etc., all fall within the protection scope and disclosure scope of the present invention.
[0106] The preferred embodiments of the present invention are described in detail above. However, the present invention is not limited to the specific details in the above embodiments. Within the technical concept of the present invention, a variety of simple modifications can be made to the technical solution of the present invention, and these simple modifications all belong to the protection scope of the present invention.
[0107] It should also be noted that the various specific technical features described in the above specific embodiments can be combined in any suitable manner without contradiction. In order to avoid unnecessary repetition, the present invention will not further describe various possible combinations.
Claims
1. A crystallization method of atracurium besylate crystal form, characterized in that: The X-ray diffraction pattern of the atracurium besylate crystal form has main characteristic peaks at 2θ of 16.01±0.2°, 18.49±0.2°, 21.42±0.2°, 22.95±0.2°, 24.89±0.2°, 27.60±0.2°, 30.08±0.2°, 31.17±0.2°, 32.19±0.2° and 35.92±0.2°; The crystallization method comprises the following steps: After dissolving amorphous atracurium besylate in acetone, adding the atracurium besylate in ethyl acetate solvent for crystallization, the atracurium besylate crystal form is obtained; The method of adding into the ethyl acetate solvent is dropwise addition; The dropping speed is 10-15 mL / h; The amount of acetone used is 0.8-2 times the weight of the amorphous atracurium besylate; The usage amount of the ethyl acetate is 7-10 mL of ethyl acetate per gram of amorphous atracurium besylate.
2. The crystallization method of atracurium besylate crystal form according to claim 1, characterized in that: The X-ray diffraction pattern of the atracurium besylate crystal form has 2θ at 15.08±0.2°, 16.01±0.2°, 18.49±0.2°, 20.11±0.2°, 21.42±0.2°, 22.95±0.2°, 23.27±0.2°, 23.80±0.2°, 24.89±0.2°, 26.16±0.2°, 27.12±0.2°, 27.60±0.2°, 27.78±0.2°, 29.52±0.2° There are characteristic peaks at 30.04±0.2°, 30.08±0.2°, 30.81±0.2°, 31.17±0.2°, 31.56±0.2°, 32.19±0.2°, 32.66±0.2°, 32.99±0.2°, 34.50±0.2°, 35.14±0.2°, 35.92±0.2°, 37.34±0.2°, 37.66±0.2°, 38.26±0.2°, 39.11±0.2° and 39.50±0.2°.
3. The crystallization method of atracurium besylate crystal form as claimed in claim 1, characterized in that, The amorphous cis-atracurium besylate is amorphous cis-atracurium besylate that has been subjected to a precipitation treatment.
4. The crystallization method of atracurium besylate crystal form as claimed in claim 1, characterized in that: The dissolution with acetone is carried out at a temperature of 18-42°C.
5. The crystallization method of atracurium besylate crystal form as claimed in claim 1, characterized in that, The dropwise addition is carried out at a temperature of 18-42°C.
6. The crystallization method of atracurium besylate crystal form according to claim 1, characterized in that: The dropwise addition is carried out under stirring conditions with a stirring speed of 200-235 rpm.
7. The crystallization method of atracurium besylate crystal form according to claim 1, characterized in that: After the dropwise addition is completed, the crystal is grown under stirring for 1.5-2.5 hours.
8. The crystallization method of atracurium besylate crystal form as claimed in claim 7, characterized in that: The stirring speed is 75-90 rpm.
9. The crystallization method of atracurium besylate crystal form as claimed in claim 7, characterized in that: The crystal growing is carried out at 18-42°C.
10. The crystallization method of atracurium besylate crystal form according to claim 1, characterized in that: After the crystallization is completed, suction filtration and drying are performed.
11. The crystallization method of atracurium besylate crystal form according to claim 10, characterized in that: The drying is performed by vacuum drying, the temperature of the vacuum drying is 25-35° C., and the time is 18-48 hours.
12. The crystallization method of atracurium besylate crystal form according to claim 1, characterized in that: The crystallization method comprises the following steps: (1) dissolving the desolvated amorphous atracurium besylate with 0.8-2 times the weight of acetone at 22-28° C.; (2) adding the acetone solution obtained in step (1) dropwise into an ethyl acetate solvent at a dropping speed of 10-15 mL / h at 18-42° C. for crystallization, stirring at a speed of 200-235 rpm while dropping, and using 7-10 mL of ethyl acetate per gram of amorphous atracurium besylate; (3) After the dropwise addition is completed, the mixture is stirred at 75-90 rpm and grown at 18-42° C. for 1.5-2.5 h, then filtered, and vacuum dried at 25-35° C. for 18-48 h to obtain the atracurium besylate crystal form.
